Bradley M. Lamm, DPM

• Head of Podiatry
• Director of Podiatric Residency Program
• Rubin Institute for Advanced Orthopedics
• International Center for Limb Lengthening
• Sinai Hospital of Baltimore
• Baltimore, Maryland

As in other conditions antibiotic handbook 400 mg myambutol purchase with amex, the radiologic response may lag behind the clinical response bacteria e coli en espanol myambutol 600 mg otc. Serologic diagnosis is based on the persistence of IgG antibody or a positive IgM titer after the first week of life (a time frame that excludes placental leak) virus yahoo discount myambutol amex. An increase in IgM beyond the first week of life is indicative of acute infection infection from cat bite purchase myambutol 400 mg otc. Up to 25% of infected newborns may be seronegative and have normal routine physical examinations bacteria 90 purchase myambutol paypal. Ocular Toxoplasmosis the serum antibody titer may not correlate with the presence of active lesions in the fundus, particularly in cases of congenital toxoplasmosis. In general, a positive IgG titer (measured in undiluted serum if necessary) in conjunction with typical lesions establishes the diagnosis. If lesions are atypical and the serum antibody titer is in the low-positive range, the diagnosis is presumptive. Accordingly, the clinical diagnosis of ocular toxoplasmosis can be supported in 60­90% of cases by laboratory tests, depending on the time of anterior chamber puncture and the panel of antibody analyses used. In the remaining cases, the possibility of a falsely negative laboratory diagnosis or of an incorrect clinical diagnosis cannot be clarified further. Depending on the signs and symptoms, prednisone (1 mg/kg per day) may be used for congenital infection. Most experts use spiramycin to treat pregnant women who have acute toxoplasmosis early in pregnancy and use pyrimethamine/sulfadiazine/folinic acid to treat women who seroconvert after 18 weeks of pregnancy or in cases of documented fetal infection. This treatment is somewhat controversial: clinical studies, which have included few untreated women, have not proven the efficacy of such therapy in preventing congenital toxoplasmosis. However, studies do suggest that treatment during pregnancy decreases the severity of infection. Many women who are infected in the first trimester elect termination of pregnancy. Those who do not terminate pregnancy are offered prenatal antibiotic therapy to reduce the frequency and severity of Toxoplasma infection in the infant. The optimal duration of treatment for a child with asymptomatic congenital toxoplasmosis is not clear, although most clinicians in the United States would treat the child for 1 year in light of cohort investigations conducted by the National Collaborative Chicago-Based Congenital Toxoplasmosis Study. Patients with ocular toxoplasmosis are usually treated for 1 month with pyrimethamine plus either sulfadiazine or clindamycin and sometimes with prednisone. Treatment should be supervised by an ophthalmologist familiar with Toxoplasma disease. Ocular disease can be self-limited without treatment, but therapy is typically considered for lesions that are severe or close to the fovea or optic disc. Prolonged treatment may prevent recurrences of ocular toxoplasmosis, but whether treatment improves long-term visual outcomes is unclear. Prophylactic monotherapy with dapsone, pyrimethamine, azithromycin, clarithromycin, or aerosolized pentamidine is probably insufficient. If seroconversion has taken place, then the patient should be given prophylaxis as described above. Discontinuation of therapy reduces the pill burden; the potential for drug toxicity, drug interaction, or selection of drug-resistant pathogens; and cost. Combination therapy with pyrimethamine plus sulfadiazine plus leucovorin is effective for this purpose. Patients need not be advised to part with their cats or to have 1615 their cats tested for toxoplasmosis. Blood intended for transfusion into Toxoplasma-seronegative immunocompromised individuals should be screened for antibody to T. Although such serologic screening is not routinely performed, seronegative women should be screened for evidence of infection several times during pregnancy if they are exposed to environmental conditions that put them at risk for infection with T. Lloyd Kasper for his numerous contributions to our understanding of the pathogenesis of toxoplasmosis and his essential role in preparation of this chapter for prior editions. Peyron F et al: Congenital toxoplasmosis in France and the United States: One parasite, two diverging approaches. Giardiasis is one of the most common parasitic diseases in both developed and developing countries worldwide, causing both endemic and epidemic intestinal disease and diarrhea. The chances of primary infection with Toxoplasma can be reduced by not eating undercooked meat and by avoiding oocystcontaminated material. Specifically, lamb, beef, and pork should be cooked to an internal temperature of 165­170°F (74­77°C); from a more practical perspective, meat cooked until it is no longer pink inside usually satisfies this requirement. Hands should be washed thoroughly after work in the garden, and all fruits and vegetables should be washed. Ingestion of raw shellfish is a risk factor for toxoplasmosis, given that the filter-feeding mechanism of clams and mussels concentrates oocysts. Litter boxes should be changed daily if possible, as freshly excreted oocysts will not have sporulated and will not be infectious. Patients should be encouraged to keep their cats inside and not to adopt or handle stray cats. Giardia remains a pathogen of the proximal small bowel and does not disseminate hematogenously. Trophozoites remain free in the lumen or attach to the mucosal epithelium by means of a ventral sucking disk. As a trophozoite encounters altered conditions, it forms a morphologically distinct cyst, which is the stage of the parasite usually found in the feces. Trophozoites may be present and even predominate in loose or watery stools, but it is the resistant cyst that survives outside the body and is responsible for transmission. Cysts do not tolerate heating or desiccation, but they do remain viable for months in cold fresh water. The number of cysts excreted varies widely but can approach 107 per gram of stool. Because cysts are infectious when excreted, person-to-person transmission occurs where fecal hygiene is poor. Giardiasis is especially prevalent in day-care centers; person-to-person spread also takes place in other institutional settings with poor fecal hygiene and during anal­ oral contact. If food is contaminated with Giardia cysts after cooking or preparation, food-borne transmission can occur. Causes: Asymptomatic infection, acute diarrhea, or chronic diarrhea and malabsorption. Small bowel may demonstrate villous blunting, crypt hypertrophy, and mucosal inflammation. Encystation occurs under conditions of bile salt concentration changes and alkaline pH. In the United States, Giardia (like Cryptosporidium; see below) is a common cause of waterborne epidemics of gastroenteritis. Giardia is common in developing countries, and infections may be acquired by travelers. Human infections are due to assemblages A and B, whereas other assemblages are more common in other animals, including cats and dogs. Like beavers from reservoirs implicated in epidemics, dogs and cats have been found to be infected with assemblages A and B; this finding suggests both that these animals may have been infected from human sources and that they might be sources of further human infections. Giardiasis, like cryptosporidiosis, creates a significant economic burden because of the costs incurred in the installation of water filtration systems required to prevent waterborne epidemics, in the management of epidemics that involve large communities, and in the evaluation and treatment of endemic infections. Pathophysiology the reasons that some, but not all, infected Cysts are ingested (10­25 cysts) in contaminated water or food or by direct fecal-oral transmission (as in day-care centers). Surface water, ranging from mountain streams to large municipal reservoirs, can become contaminated with fecally derived Giardia cysts. The efficacy of water as a means of transmission is enhanced by the small infectious inoculum of Giardia, the prolonged survival of cysts in cold water, and the resistance patients develop clinical manifestations and the mechanisms by which Giardia causes alterations in small-bowel function are largely unknown. Although trophozoites adhere to the epithelium, they are not invasive but may elicit apoptosis of enterocytes, epithelial barrier dysfunction, and epithelial cell malabsorption and secretion. Consequent lactose intolerance and, in a minority of infected adults and children, significant malabsorption are clinical signs of the loss of brush-border enzyme activities. In most infections, the morphology of the bowel is unaltered; however, in chronically infected, symptomatic patients, the histopathologic findings (including flattened villi) and the clinical manifestations at times resemble those of tropical sprue and glutensensitive enteropathy. Parasite as well as host factors may be important in determining the course of infection and disease. Both cellular and humoral responses develop in human infections, but their precise roles in disease pathogenesis and/or control of infection are unknown. Because patients with hypogammaglobulinemia suffer from prolonged, severe infections that are poorly responsive to treatment, humoral immune responses appear to be important. The greater susceptibilities of the young than of the old and of newly exposed persons than of chronically exposed populations suggest that at least partial protective immunity may develop. Clinical Manifestations Disease manifestations of giardiasis range from asymptomatic carriage to fulminant diarrhea and malabsorption. Most infected persons are asymptomatic, but in epidemics the proportion of symptomatic cases may be higher. In persons with acute giardiasis, symptoms develop after an incubation period that lasts at least 5­6 days and usually 1­3 weeks. Prominent early symptoms include diarrhea, abdominal pain, bloating, belching, flatus, nausea, and vomiting. Although diarrhea is common, upper intestinal manifestations such as nausea, vomiting, bloating, and abdominal pain may predominate. The duration of acute giardiasis is usually >1 week, although diarrhea often subsides. Individuals with chronic giardiasis may present with or without having experienced an antecedent acute symptomatic episode. Diarrhea is not necessarily prominent, but increased flatus, loose stools, sulfurous belching, and (in some instances) weight loss occur. Some persons who have relatively mild symptoms for long periods recognize the extent of their discomfort only in retrospect. Fever, the presence of blood and/or mucus in the stools, and other signs and symptoms of colitis are uncommon and suggest a different diagnosis or a concomitant illness. Symptoms tend to be intermittent yet recurring and gradually debilitating, in contrast with the acute disabling symptoms associated with many enteric bacterial infections. Because of the less severe illness early on and the propensity for chronic infections, patients may seek medical advice late in the course of the illness; however, disease can be severe, resulting in malabsorption, weight loss, growth retardation, and dehydration. A number of extraintestinal manifestations have been described, such as urticaria, anterior uveitis, and arthritis; whether these are caused by giardiasis or concomitant processes is unclear. Giardiasis can be severe in patients with hypogammaglobulinemia and can complicate other preexisting intestinal diseases, such as that occurring in cystic fibrosis. Cysts are oval, measure 8­12 m × 7­10 m, and characteristically contain four nuclei. Direct examination of fresh or properly preserved stools as well as concentration methods should be used. Because cyst excretion is variable and may be undetectable at times, repeated examination of stool, sampling of duodenal fluid, and biopsy of the small intestine may be required to detect the parasite. Tests for parasitic antigens in stool are at least as sensitive and specific as good microscopic examinations and are easier to perform. Life Cycle and Epidemiology Cryptosporidium species are widely distributed in the world. Cryptosporidiosis is acquired by the consumption of oocysts (50% infectious dose: ~132 C. Since oocysts are immediately infectious when passed in feces, person-to-person transmission takes place in day-care centers and among household contacts and medical providers. Pathophysiology Although intestinal epithelial cells harbor cryptosporidia in an intracellular vacuole, the means by which secretory diarrhea is elicited remain uncertain. The distribution of infection can be spotty within the principal site of infection, the small bowel. Cryptosporidia are found in the pharynx, stomach, and large bowel of some patients and at times in the respiratory tract. In immunocompetent persons, symptoms develop after an incubation period of ~1 week and consist principally of watery nonbloody diarrhea, sometimes in conjunction with abdominal pain, nausea, anorexia, fever, and/or weight loss. Biliary tract involvement can manifest as mid-epigastric or right-upper-quadrant pain. Because conventional stool examination for ova and parasites (O+P) does not detect Cryptosporidium, specific testing must be requested. Detection is enhanced by evaluation of stools (obtained on multiple days) by several techniques, including modified acid-fast and direct immunofluorescent stains and enzyme immunoassays. Cryptosporidia can also be identified by light and electron microscopy at the apical surfaces of intestinal epithelium from biopsy specimens of the small bowel and, less frequently, the large bowel. Nitazoxanide (500 mg twice daily for 3 days) is an alternative agent for treatment of giardiasis. Paromomycin, an oral aminoglycoside that is not well absorbed, can be given to symptomatic pregnant patients, although information is limited on how effectively this agent eradicates infection. Almost all patients respond to therapy and are cured, although some with chronic giardiasis experience delayed resolution of symptoms after eradication of Giardia. For many of the latter patients, residual symptoms probably reflect delayed regeneration of intestinal brush-border enzymes. Continued infection should be documented by stool examinations before treatment is repeated. Patients who remain infected after repeated treatments should be evaluated for reinfection through family members, close personal contacts, and environmental sources as well as for hypogammaglobulinemia. In cases refractory to multiple treatment courses, prolonged therapy with metronidazole (750 mg thrice daily for 21 days) or therapy with varied combinations of multiple agents has been successful.

The seven major human adenovirus species (designated A through G) fall into 57 immunologically distinct serotypes antibiotics joint replacement dental work 800 mg myambutol order with amex. Many serotypes cause sporadic outbreaks antibiotic ointment order myambutol american express, while others appear to be endemic in particular locations treatment for uti burning cost of myambutol. Respiratory illnesses include mild disease such as the common cold and lower respiratory tract illnesses including croup antibiotics vs alcohol trusted myambutol 400 mg, bronchiolitis bacteria on tongue myambutol 800 mg purchase line, and pneumonia. A particular constellation of symptoms referred to as pharyngoconjunctival fever is frequently associated with acute adenovirus infection. In contrast, gastroenteritis has been associated most frequently with serotypes 40 and 41 virus of species F. Immunocompromised patients are highly susceptible to severe disease during infection with respiratory adenoviruses. Papovaviridae: Polyomaviruses Polyomaviruses are small, 1379 Coronaviridae Members of the genus Coronavirus also contribute to respiratory illness, including severe disease. The one major epidemic to date (November 2002 through July 2003) encompassed more than 8000 cases, with mortality rates approaching 10%. Typically, patients present with a nonspecific illness manifesting as fever, myalgia, malaise, and chills or rigors; watery diarrhea may occur as well. Evidence is emerging that this new group 1 coronavirus is a common respiratory pathogen of humans, causing both upper and lower respiratory tract illness. Several cases of respiratory illness have been associated with this virus, but its infrequent identification suggests that this putative group 2 coronavirus has caused a low incidence of illness to date. Studies have shown that humans are infected through direct or indirect contact with infected dromedary camels. Herpesviridae Several herpesviruses cause upper respiratory infections, especially infection of the oral cavity. Herpes simplex pharyngitis is associated with characteristic clinical findings, such as acute ulcerative stomatitis and ulcerative pharyngitis. Primary oral disease can be severe, especially in young children, who sometimes are admitted for rehydration therapy as a result of poor oral intake. A significant proportion of individuals suffer recurrences of symptomatic disease consisting of vesicles on the lips. Parvoviridae: Human Bocavirus A new virus was recently identified in respiratory samples from children with lower respiratory tract disease in Sweden. Sequence analysis of the genome revealed that the virus is highly related to canine minute virus and bovine parvovirus and is a member of the genus Bocavirus (subfamily Parvovirinae, family Parvoviridae). Whether the virus causes or is merely associated with disease remains controversial. Primary infection with most of the acute respiratory viruses often is more severe than secondary infection. Indeed, reinfection with most of these viruses occurs throughout life, but primary infection is much more likely to be associated with severe lower respiratory tract disease, while secondary infection typically is asymptomatic or associated with upper respiratory tract symptoms only. As these infections are ubiquitous, most primary infections (and thus many of the severe cases) occur during the first few years of life. Later, exposure to young children (in populations such as parents of young children and daycare workers) is a risk factor for frequent reinfection. Despite a lifetime of previous exposures, the risk of severe disease increases with age in the elderly, probably because of immune senescence and general medical decline. Typically, there is one dominant virus sweeping through a local community at any one time, a pattern that suggests some population-level interference with transmission. However, outbreaks can be closely spaced, and co-circulation of different viruses or antigenically diverse strains of one virus does occur. Seasons are, of course, reversed in the Northern and Southern hemispheres, so that winter epidemics occur roughly from November to March in the United States but from April to August in Australia; therefore, "winter" epidemics are almost always occurring somewhere in the world. Seasonal variances differ in the tropics, where acute respiratory viral infections are more common in the rainy season. Most single risk factors identified have a moderate effect on the incidence of severe disease, but an accumulation of factors is associated with high risk. Underlying lung disease is a major factor, especially diseases associated with the need for chronic oxygen supplementation. Other severe underlying medical conditions, especially cardiovascular disease, also enhance risk. Smoking (or exposure to wood smoke), low socioeconomic status, and male gender all contribute to a minor increase in the risk of lower respiratory tract illness. A breakdown in isolation and hand-washing compliance procedures can lead to cycles of nosocomial transmission of infection in hospital inpatient wards and intensive care units. In assessments of severe lower respiratory tract illness, a history of travel to an area with unusual agents should be considered carefully. Therefore, contact and droplet precautions are sufficient to prevent transmission in most settings; hand washing is especially critical in health care settings during the winter. Multiplex panels assaying a sample for a dozen or more common respiratory viruses are available. These tests must be used and interpreted carefully because of their extreme sensitivity. In addition, because a viral genome can sometimes persist in nasal secretions for weeks after an infection resolves, a positive test may indicate a recently resolved rather than a currently acute infection. Hypoxia is managed with supplemental oxygen and respiratory failure with mechanical ventilation. Because the tachypnea and fever that often accompany pneumonia and wheezing frequently result in dehydration, fluid management is important. The astute clinician can narrow the etiologic possibilities on the basis of epidemiologic knowledge; information about viruses circulating in the community (widely available from local reference laboratories, county and state health departments, and the U. When diagnostic tests are applied only to samples from individuals at high risk of exposure to an infectious agent in the appropriate season, the positive predictive value of the test is increased. A central medical decision is whether or not to use a specific antibacterial or antiviral agent to treat a respiratory infection. Antibiotics do not improve the outcome of uncomplicated respiratory virus infections in otherwise healthy subjects. Some viral infections, especially influenza, can be complicated by secondary bacterial infection. There are only a limited number of licensed antiviral drugs, which should be used when a specific viral etiology is determined. Antiviral treatment generally is effective only when administered early in the course of illness. Neuraminidase inhibitors act on both influenza A and B viruses by serving as transition-state analogs of the viral neuraminidase that is needed to release newly budded virion progeny from the surface of infected cells. Oseltamivir is administered orally and is effective for the prevention or treatment of uncomplicated influenza in otherwise healthy adults. Observational studies indicate that oseltamivir also may be beneficial during serious illness. Zanamivir, a powder that is administered through oral inhalation, exhibits effectiveness similar to that of oseltamivir. Moreover, zanamivir is active against some influenza virus strains that are resistant to oseltamivir. Peramivir is a newer drug that is administered intravenously as a single 600-mg dose. It is efficacious in acute, uncomplicated influenza and is approved for treatment of individuals who cannot take oral or inhaled medications. Its efficacy in severe influenza requiring hospitalization has not yet been demonstrated. Laninamivir is a new drug that is approved in Japan for prophylaxis and treatment of influenza. It is a polymeric zanamivir conjugate that is delivered by oral inhalation, and it exhibits greater potency and longer retention times than conventional zanamivir. The adamantanes amantadine and rimantidine have been used for the treatment of influenza A infection. These drugs interfere with the ion channel activity caused by the M2 protein of influenza A viruses, which is needed for viral particle uncoating after endocytosis. These agents were commonly used in the past, but widespread resistance has been found in many currently circulating influenza A viruses. When they are used, they are administered orally and display efficacy against uncomplicated influenza A caused by susceptible strains. Toxicity with amantadine is primarily associated with central nervous system symptoms. The efficacy of aerosolized ribavirin therapy remains uncertain despite a number of clinical trials. Bronchiolitis is an acute illness with wheezing and evidence of upper respiratory infection, most commonly seen in the winter in infants and young children. The typical clinical manifestations of acute pneumonia include cough, sputum production, dyspnea, and chest pain. More systemic signs and symptoms also occur in pneumonia, including fever, fatigue, sweats, headache, myalgia, and occasionally nausea, abdominal pain, and diarrhea. The gold standard for diagnosing a respiratory viral infection is virus isolation, performed by inoculation of cell cultures with fresh secretions and use of multiple cell types in a reference laboratory staffed by experienced technologists. Direct or indirect fluorescent antibody detection can be used to visualize virus-infected cells in nasal secretions. Pleconaril reduces mucus secretions and other symptoms and is being further examined for this indication. Acyclovir and related compounds are guanine-analog antiviral drugs used in the treatment of herpesvirus infections. These compounds have also been used prophylactically to prevent the recurrence of outbreaks, with mixed results. Cidofovir is a nucleotide analog with activity against a large number of viruses, including adenoviruses. Intravenous cidofovir has been effective in the management of severe adenoviral infection in immunocompromised patients but may cause serious nephrotoxicity. Next-generation antibodies with higher potency and an extended half-life of ~90 days are being tested. In general, in careful studies using cell culture techniques for virus isolation, two or more viruses were isolated from respiratory secretions of otherwise healthy adults with acute respiratory illness in ~5­10% of cases. Vaccines are effective when the vaccine strains chosen for inclusion are highly related antigenically to the epidemic strain, but occasional antigenic mismatches cause negligible efficacy of a vaccine component. Antigenic drift caused by point mutations in the H and N molecules leads to antigenic divergence, requiring the production of new vaccines each year. The segmented influenza genome allows reassortment of two viruses during co-infection of one individual or animal; sometimes the consequence is a major antigenic shift resulting in a pandemic. There is current concern about the potential for an H5N1 or H7N9 pandemic, and experimental vaccines are being tested for these viruses. Vaccines were developed for adenovirus serotypes 4 and 7 and were approved for prevention of epidemic respiratory illness among military recruits. Essentially, these vaccines consisted of unmodified viruses given by the enteric route in capsules instead of by the respiratory route-the natural route of infection leading to disease. Inoculation by the altered route resulted in an immunizing asymptomatic infection. There are no licensed vaccines against rhinoviruses; as there is little or no cross-protection between serotypes, it will be challenging to develop Most respiratory viruses are spread by direct contact-i. Poor hand hygiene is probably the most common cause of contact transmission of viruses, which occurs often in family, school, and workplace settings. Transmission between health care workers and patients also takes place when hand-washing compliance is low. Fomites (objects or substances capable of carrying infectious organisms), including instruments, stethoscopes, and other objects in medical environments, can contribute to transmission. Airborne transmission can occur but is probably not the dominant mode of transmission for most respiratory viruses. The composition and size distribution of the generated particles affect the duration of suspension of the infectious agents in the air, the distance across which they can be transported, the interval during which the virus remains infectious, and the site of deposition in the airway of a susceptible host. Particles of small size can remain suspended in the air for long periods; for instance, particles of ~1 m can remain suspended for hours. However, in general, only a few respiratory viruses are thought to be transmitted by small-particle aerosols. Protection from transmission in health care environments can be achieved by proper implementation of and adherence to established procedures for the appropriate level of precaution. Contact precautions, the second level, require a single room for the patient when possible and the use of additional personal protective equipment, including the wearing of clean, nonsterile gloves when touching a patient or coming into contact with secretions. Fluid-resistant nonsterile gowns are used to protect skin and clothing during activities where contact with secretions is anticipated, and providers should wear each gown for the care of only one patient. A face mask is used when there is potential for direct contact with respiratory secretions. Eye protection (goggles or face shields) is worn in anticipation of potential splashing of respiratory secretions. Good hand hygiene should always follow any patient contact, including washing for 20 seconds with soap and warm water or cleaning with an alcohol-based hand rub. Providers should attempt to avoid the contamination of clothing and the transfer of microorganisms to other patients, surfaces, or environments. Droplet Precautions Large-particle droplets are generated dur- ing sneezing and coughing and during the performance of some medical procedures, such as airway suctioning in critical care units or bronchoscopy. Such droplets may contain viruses, but their range is usually limited to about 3 ft. Transmission of large-particle droplets occurs when they are deposited on the nasal mucosa or conjunctivae. To prevent transmission in these settings, providers should implement droplet precautions. They should wear a face mask, such as a surgical mask, for close contact (within 3 ft of the patient).

Widespread use of ivermectin for treatment of intestinal nematode infections in sheep and goats has led to the emergence of drug resistance in veterinary practice; this development may portend problems in human medical use antibiotic resistance washington post cheap myambutol 800 mg visa. Data suggest that ivermectin acts by opening the neuromuscular membrane-associated fast acting antibiotics for acne cheap myambutol 600 mg online, glutamate-dependent chloride channels antibiotics for dogs chest infection order myambutol 400 mg amex. The influx of chloride ions results in hyperpolarization and muscle paralysis-particularly of the nematode pharynx antibiotics have no effect on quizlet best myambutol 400 mg, with consequent blockage of the oral ingestion of nutrients bacteria function cost of myambutol. As these chloride channels are present only in invertebrates, paralysis is seen only in the parasite. Ivermectin is distributed widely throughout the body; animal studies indicate that it accumulates at the highest concentration in adipose tissue and liver, with little accumulation in the brain. Few data exist to guide therapy in hosts with conditions that may influence drug pharmacokinetics. In the absence of parasitic infection, the adverse effects of ivermectin in therapeutic doses are minimal. Adverse effects in patients with filarial infections include fever, myalgia, malaise, lightheadedness, and (occasionally) postural hypotension. The severity of such side effects is related to the intensity of parasite infection, with more symptoms in individuals with a heavy parasite burden. In onchocerciasis, Mefloquine Mefloquine is effective prophylaxis of chloroquine- resistant malaria; high doses can be used for treatment. Cross-resistance of mefloquine with halofantrine and with quinine has been documented in limited areas. Like quinine and chloroquine, this quinoline is active only against the asexual erythrocytic stages of malarial parasites. Although both mefloquine and chloroquine inhibit hemozoin formation and heme degradation, mefloquine differs in that it forms a complex with heme that may be toxic to the parasite. Its absorption is adversely affected by vomiting and diarrhea but is significantly enhanced when the drug is administered with or after food. Mefloquine is excreted mainly in the bile and feces; therefore, no dose adjustment is needed in persons with renal insufficiency. No special chemoprophylactic dosage adjustments are indicated for the achievement of plasma concentrations in dialysis patients that are similar to those in healthy persons. Pharmacokinetic differences have been detected among various ethnic populations; however, these distinctions are of minor importance compared with host immune status and parasite sensitivity. In patients with impaired liver function, the elimination of mefloquine may be prolonged, leading to higher plasma levels. Mefloquine should be used with caution by individuals participating in activities requiring alertness and fine-motor coordination because dizziness, vertigo, or tinnitus can develop and persist. If the drug is to be administered for a prolonged period, periodic evaluations are recommended, including liver function tests and ophthalmic examinations. Psychosis and seizures occur rarely; mefloquine should not be prescribed to patients with neuropsychiatric conditions. The development of acute anxiety, depression, restlessness, or confusion may be considered prodromal to a more serious event, and the drug should be discontinued. Concomitant use of quinine, quinidine, or drugs producing -adrenergic blockade may cause significant electrocardiographic abnormalities or cardiac arrest. Administration of mefloquine with quinine or chloroquine may increase the risk of convulsions. Vaccinations with attenuated live bacteria should be completed at least 3 days before the first dose of mefloquine. Women of childbearing age who are traveling to areas where malaria is endemic should be warned against becoming pregnant and encouraged to practice contraception during malaria prophylaxis with mefloquine and for up to 3 months thereafter. However, in the case of unplanned pregnancy, use of mefloquine is not considered an indication for pregnancy termination. Analysis of prospectively monitored cases demonstrates a prevalence of birth defects and fetal loss comparable to background rates. Schistosomal cholinesterase is more 1565 susceptible to dichlorvos than is the corresponding human enzyme. The exact mechanism of action of metrifonate is uncertain, but the drug is believed to inhibit tegumental acetylcholine receptors that mediate glucose transport. After a single oral dose, metrifonate produces a 95% decrease in plasma cholinesterase activity within 6 h, with a fairly rapid return to normal. Treated persons should not be exposed to neuromuscular blocking agents or organophosphate insecticides for at least 48 h after treatment. Metronidazole and Other Nitroimidazoles See Table 217-1 Miltefosine In the early 1990s, miltefosine (hexadecylphosphocho- Melarsoprol* Melarsoprol has been used since 1949 for the treat- ment of human African trypanosomiasis. This trivalent arsenical compound is indicated for the treatment of African trypanosomiasis with neurologic involvement and for the treatment of early disease that is resistant to suramin or pentamidine. Melarsoprol, like other drugs containing heavy metals, interacts with thiol groups of several different proteins; however, its antiparasitic effects appear to be more specific. Trypanothione reductase is a key enzyme involved in the oxidative stress management of both Trypanosoma and Leishmania species, helping to maintain an intracellular reducing environment by reduction of disulfide trypanothione to its dithiol derivative dihydrotrypanothione. Melarsoprol sequesters dihydrotrypanothione, depriving the parasite of its main sulfhydryl antioxidant, and inhibits trypanothione reductase, depriving the parasite of the essential enzyme system that is responsible for keeping trypanothione reduced. The selectivity of arsenical action against trypanosomes is due at least in part to the greater melarsoprol affinity of reduced trypanothione than of other monothiols. Melarsoprol enters the parasite via an adenosine transporter; drug-resistant strains lack this transport system. The most serious adverse reaction is reactive encephalopathy, which affects 6% of treated individuals and usually develops within 4 days of the start of therapy, with an average case­fatality rate of 50%. Because melarsoprol is intensely irritating, care must be taken to avoid infiltration of the drug. Miltefosine is the first oral drug that has proved to be highly effective and comparable to amphotericin B against visceral leishmaniasis in India, where antimonial-resistant cases are prevalent. Cure rates in cutaneous leishmaniasis are comparable to those obtained with antimony. The activity of miltefosine is attributed to interaction with cell signal transduction pathways and inhibition of phospholipid and sterol biosynthesis. The efficacy of a 28-day treatment course in Indian visceral leishmaniasis is equivalent to that of amphotericin B therapy; however, it appears that a shortened course of 21 days may be equally efficacious. Its use is limited by its side effects, the necessarily long duration of therapy, the recommended use of purgatives, and-most important-limited availability. Tablets are given on an empty stomach in the morning after a liquid meal the night before, and this dose is followed by another 1 h later. The scolex and proximal segments of the tapeworms are killed on contact with niclosamide and may be digested in the gut. However, disintegration of the adult tapeworm results in the release of viable ova, which theoretically can result in autoinfection. Although fears of the development of cysticercosis in patients with Taenia solium infections have proved unfounded, it is still recommended that a brisk purgative be given 2 h after the first dose. Nifurtimox* this nitrofuran compound is an inexpensive and effective oral agent for the treatment of acute Chagas disease. Trypanosomes lack catalase and have very low levels of peroxidase; as a result, they are very vulnerable to by-products of oxygen reduction. Despite the Metrifonate Metrifonate has selective activity against Schistosoma haematobium. Prolonged use is required, but the course may have to be interrupted because of drug toxicity, which develops in 40­70% of recipients. Nifurtimox is well absorbed and undergoes rapid and extensive biotransformation; <0. Nitazoxanide Nitazoxanide is a 5-nitrothiazole compound used for the treatment of cryptosporidiosis and giardiasis; it is active against other intestinal protozoa as well. After oral administration, nitazoxanide is rapidly hydrolyzed to an active metabolite, tizoxanide (desacetyl-nitazoxanide). It is recommended that nitazoxanide be taken with food; however, no studies have been conducted to determine whether the pharmacokinetics of tizoxanide and tizoxanide glucuronide differ in fasted versus fed subjects. Tizoxanide is excreted in urine, bile, and feces, and tizoxanide glucuronide is excreted in urine and bile. The pharmacokinetics of nitazoxanide in patients with impaired hepatic and/or renal function have not been studied. Therefore, caution should be used when administering this agent concurrently with other highly plasma protein­bound drugs that have narrow therapeutic indices, as competition for binding sites may occur. In treated adult schistosomes, oxamniquine produces marked tegumental alterations that are similar to those seen with praziquantel but that develop less rapidly, becoming evident 4­8 days after treatment. About 70% of an administered dose is excreted in urine as a mixture of pharmacologically inactive metabolites. Patients should be warned that their urine might have an intense orange­red color. Side effects are uncommon and usually mild, although hallucinations and seizures have been reported. Pentamidine isethionate is well absorbed, highly tissue bound, and excreted slowly over several weeks, with an elimination half-life of 12 days. No steady-state plasma concentration is attained in persons given daily injections; the result is extensive accumulation of pentamidine in tissues, primarily the liver, kidney, adrenal gland, and spleen. Pulmonary concentrations of pentamidine are increased when the drug is delivered in aerosolized form, but not when it is delivered systemically. Because electrolyte disturbances and mild to moderate nephrotoxicity occur commonly, pentamidine should be used with caution with other nephrotoxic agents. Similarly, hypoglycemia can develop, although much less commonly when pentamidine is given by the inhaled route. Piperaquine this bisquinoline was synthesized in the 1960s and used widely for malaria control in China. The development of artemisinin-based combination therapy led to its evaluation as a partner drug, and it is now combined with dihydroartemisinin. Piperaquine is highly lipophilic and has a prolonged half-life (~20 days), thus providing a period of post-treatment prophylaxis. Piperazine the antihelminthic activity of piperazine is confined to ascariasis and enterobiasis. Although the initial result is hyperpolarization of the muscle fibers, the ultimate effect is flaccid paralysis, leading to the expulsion of live worms. Praziquantel this heterocyclic pyrazinoisoquinoline derivative is highly active against a broad spectrum of trematodes and cestodes. It is the mainstay of treatment for schistosomiasis and is a critical part of community-based control programs. All of the effects of praziquantel can be attributed either directly or indirectly to an alteration of intracellular calcium concentrations. Although the exact mechanism of action remains unclear, the major mechanism is disruption of the parasite tegument, causing tetanic contractures with loss of adherence to host tissues and, ultimately, disintegration or expulsion. Praziquantel induces changes in the antigenicity of the parasite by causing the exposure of concealed antigens. Praziquantel exerts its parasitic effects directly and does not need to be metabolized to be effective. Levels of the drug are increased when it is taken with food, particularly carbohydrates, or with cimetidine. Serum levels are reduced by glucocorticoids, chloroquine, carbamazepine, and phenytoin. Praziquantel is completely metabolized in humans, with 80% of the dose recovered as metabolites in urine within 4 days. It is not known to what extent praziquantel crosses the placenta, but retrospective studies suggest that it is safe in pregnancy. Patients with schistosomiasis who have heavy parasite burdens may develop abdominal discomfort, nausea, headache, dizziness, and drowsiness. Symptoms begin 30 min after ingestion, may require spasmolytics for relief, and usually disappear spontaneously after a few hours. Parenteral paromomycin appears to be effective against visceral leishmaniasis in India. If absorbed or administered systemically, paromomycin can cause ototoxicity and nephrotoxicity. However, systemic absorption is very limited, and toxicity should not be a concern in persons with normal kidneys. Pentamidine Isethionate this diamidine is an effective alternative agent for some forms of leishmaniasis and trypanosomiasis. It is Primaquine Phosphate Primaquine, an 8-aminoquinoline, has a broad spectrum of activity against all stages of plasmodial development in humans but has been used most effectively for eradication of the hepatic stage of these parasites. It is, in fact, rapidly metabolized; only a small fraction of the dose of the parent drug is excreted unchanged. Although the parasiticidal activity of the three oxidative metabolites remains unclear, they are believed to affect both pyrimidine synthesis and the mitochondrial electron transport chain. The metabolites appear to have significantly less antimalarial activity than primaquine; however, their hemolytic activity is greater than that of the parent drug. Primaquine causes marked hypotension after parenteral administration and therefore is given only by the oral route. Proguanil exerts its effect primarily by means of the metabolite cycloguanil, whose inhibition of dihydrofolate reductase in the parasite disrupts deoxythymidylate synthesis, thus interfering with a key pathway involved in the biosynthesis of pyrimidines required for nucleic acid replication. There are no clinical data indicating that folate supplementation diminishes drug efficacy; women of childbearing age for whom atovaquone/proguanil is prescribed should continue taking folate supplements to prevent neural tube birth defects. The main routes of elimination are hepatic biotransformation and renal excretion; 40­60% of the proguanil dose is excreted by the kidneys. Drug levels are increased and elimination is impaired in patients with hepatic insufficiency. At the usual dosage, pyrimethamine alone causes little toxicity 1567 except for occasional skin rashes and, more rarely, blood dyscrasias. Bone marrow suppression sometimes occurs at the higher doses used for toxoplasmosis; at these doses, the drug should be administered with folinic acid.

Malaria anemia is worsened by concurrent infections with intestinal helminths antimicrobial infections purchase myambutol with amex, hookworm in particular bacteria at 8 degrees 800 mg myambutol purchase fast delivery. Differentiating severe malaria from sepsis with incidental parasitemia in childhood is very difficult antibiotic resistance among bacteria buy myambutol in india. Chest infections and catheter-induced urinary tract infections are common among patients who are unconscious for >3 days antibiotic poisoning order discount myambutol online. The frequencies of complications of severe falciparum malaria are summarized in Table 219-4 recommended antibiotics for acne myambutol 600 mg order visa. Malaria can be transmitted by blood transfusion, needlestick injury, or organ transplantation. The incubation period in these settings is often short because there is no preerythrocytic stage of development. The clinical features and management of these cases are the same as for naturally acquired infections. Radical chemotherapy with primaquine is unnecessary for transfusion-transmitted P. Some residents of malaria-endemic areas in tropical countries exhibit an abnormal immunologic response to repeated infections that is characterized by massive splenomegaly, hepatomegaly, marked elevations in serum IgM and malarial antibody titers, hepatic sinusoidal lymphocytosis, and (in Africa) peripheral B cell lymphocytosis. These events may lead to uninhibited B cell production of IgM and the formation of cryoglobulins (IgM aggregates and immune complexes). This immunologic process stimulates lymphoid hyperplasia and clearance activity and eventually produces splenomegaly. Patients with hyperreactive malarial splenomegaly present with an abdominal mass or a dragging sensation in the abdomen and occasional sharp abdominal pains suggesting perisplenitis. In some cases, malaria parasites cannot be found in peripheral-blood smears by microscopy. Vulnerability to respiratory and skin infections is increased; many patients die of overwhelming sepsis. Persons with hyperreactive malarial splenomegaly living in endemic areas should receive antimalarial chemoprophylaxis; the results are usually good. However, in other cases refractory to therapy, clonal lymphoproliferation may develop and can evolve into a malignant lymphoproliferative disorder. Other unidentified factors must contribute to this process since only a very small proportion of infected patients develop renal disease. The histologic appearance is that of focal or segmental glomerulonephritis with splitting of the capillary basement membrane. Subendothelial dense deposits are seen on electron microscopy, and immunofluorescence reveals deposits of complement and immunoglobulins; in samples of renal tissue from children, P. A coarse-granular pattern of basement membrane immunofluorescent deposits (predominantly IgG3) with selective proteinuria carries a better prognosis than a fine-granular, predominantly IgG2 pattern with nonselective proteinuria. It usually responds poorly to treatment with either antimalarial agents or glucocorticoids and cytotoxic drugs. The prevalence of this childhood tumor is high in high-malaria-transmission areas of Africa. Staining of parasites with the fluorescent dye acridine orange allows more rapid diagnosis of malaria (but not speciation of the infection) in patients with low-level parasitemia. As many layers of erythrocytes overlie one another and are lysed during the staining procedure, the thick film has the advantage of concentrating the parasites (by 40- to 100-fold compared with a thin blood film) and thus increasing diagnostic sensitivity. This figure is converted to the number of parasitized erythrocytes per microliter. Interpretation of blood smears, particularly thick films, requires some experience because artifacts are common. In high-transmission areas, the presence of up to 10,000 parasites/L of blood may be tolerated without symptoms or signs in partially immune individuals. Thus, in these areas, the detection of low-density malaria parasitemia is sensitive but has low specificity in identifying malaria as the cause of illness. In severe malaria, assess stage of parasite development and count neutrophils containing malaria pigment. Rapid, simple, sensitive, and specific antibody-based diagnostic stick or card tests that detect P. Some of these rapid diagnostic tests carry a second antibody (either pan-malaria or P. The relationship between parasite density and prognosis is complex; in general, patients with >105 parasites/L are at increased risk of dying, but nonimmune patients may die with much lower counts, and partially immune persons may tolerate parasitemia levels many times higher with only minor symptoms. In severe malaria, a poor prognosis is indicated by a predominance of more mature P. Microtube Blood is collected in a specialized tube containing concentration methods acridine orange, anticoagulant, and a float. After with acridine orange centrifugation, which concentrates the parasitized staining cells around the float, fluorescence microscopy is performed. In areas of the world where malaria is endemic and transmission rates are high, low-level asymptomatic parasitemia is common in otherwise healthy people. Thus malaria may not be the cause of a fever, although in this context the presence of >10,000 parasites/L (~0. At any level of parasitemia, the finding that >50% of parasites are tiny rings (cytoplasm thickness less than half of nucleus width) carries a relatively good prognosis. The presence of visible pigment in >20% of parasites or of phagocytosed pigment in >5% of polymorphonuclear leukocytes (indicating massive recent schizogony) carries a worse prognosis. Phagocytosed malarial pigment seen inside peripheral-blood monocytes may provide a clue to recent infection if malaria parasites are not detectable. After parasite clearance, this intraphagocytic malarial pigment is often evident for several days in peripheral-blood films or for longer in bone marrow aspirates or smears of fluid expressed after intradermal puncture. Serologic diagnosis with either indirect fluorescent antibody or enzyme-linked immunosorbent assays is useful for screening of prospective blood donors and may prove useful as a measure of transmission intensity in future epidemiologic studies. Significant artemisinin resistance is now prevalent throughout the Greater Mekong subregion but has not been reported from other malaria-endemic regions. Falsified or substandard antimalarial drugs are sold in many Asian and African countries and may be the cause of a failure to respond to therapy. Artesunate therefore is now the drug of choice for all patients with severe malaria everywhere. A rectal formulation of artesunate has been developed as a community-based pre-referral treatment for patients in the rural tropics who cannot take oral medications. Pre-referral administration of rectal artesunate has been shown to decrease mortality rates among severely ill children without access to immediate parenteral treatment. Although the artemisinin compounds are safer than quinine and considerably safer than quinidine, only one formulation is available in the United States. The antiarrhythmic quinidine gluconate was used to treat severe malaria in the United States previously but is now in short supply; artesunate is much more effective and safer. Parenteral quinidine is potentially dangerous and must be closely monitored if dysrhythmias and hypotension are to be avoided. If arrhythmia or saline-unresponsive hypotension develops, treatment with this drug should be discontinued. Quinine is safer than quinidine; cardiovascular monitoring is not required except when the recipient has cardiac disease. Although parenteral quinine is steadily being replaced by parenteral artesunate in endemic areas, it still has a role in the very few cases of artemisinin-resistant severe falciparum malaria from Southeast Asia, where both artesunate and quinine are given together in full doses. Severe falciparum malaria constitutes a medical emergency requiring intensive nursing care and careful management. Adjunctive treatments such as high-dose glucocorticoids, urea, heparin, dextran, desferrioxamine, antibody to tumor necrosis factor, high-dose phenobarbital (20 mg/kg), mannitol, or large-volume fluid or albumin boluses have proved either ineffective or harmful in clinical trials and should not be used. In acute renal failure or severe metabolic acidosis, hemofiltration or hemodialysis should be started as early as possible. In severe malaria, parenteral antimalarial treatment should be started immediately. If artesunate is unavailable and artemether, quinine, or quinidine is used, an initial loading dose must be given so that therapeutic concentrations are reached as soon as possible. Both quinine and quinidine will cause dangerous hypotension if Normochromic, normocytic anemia is usual. The leukocyte count is generally normal, although it may be raised in very severe infections. There is slight monocytosis, lymphopenia, and eosinopenia, with reactive lymphocytosis and eosinophilia in the weeks after acute infection. The erythrocyte sedimentation rate, plasma viscosity, and levels of C-reactive protein and other acute-phase proteins are elevated. Severe infections may be accompanied by prolonged prothrombin and partial thromboplastin times and by more severe thrombocytopenia. Hypergammaglobulinemia is usual in immune and semi-immune subjects living in malaria-endemic areas. Antimalarial drug susceptibility testing can be performed but is rarely available, has poor predictive value in an individual case, and yields results too slowly to influence the choice of treatment. If there is any doubt about the resistance status of the infecting organism, it should be considered resistant. Artemisinin-based combinations are sometimes unavailable in temperate countries, where treatment recommendations are limited to the registered available drugs. Clindamycin (10 mg/kg bid for 7 days) or Atovaquone-proguanil (20/8 mg/kg qd for 3 days with food) Artesunated (2. The World Health Organization now recommends artemisinin combination regimens as first-line therapy for falciparum malaria in all tropical countries and advocates use of fixed-dose combinations. The data from large studies in Southeast Asia showed a 35% lower mortality rate than with quinine, and very large studies in Africa showed a 22. The optimal therapeutic ranges for quinine and quinidine in severe malaria are not known with certainty, but total plasma concentrations of 8­15 mg/L for quinine and 3. The systemic clearance and apparent volume of distribution of these alkaloids are markedly reduced and plasma protein binding is increased in severe malaria, so that the blood concentrations attained with a given dose are higher. If the patient remains seriously ill or in acute renal failure for >2 days, maintenance doses of quinine or quinidine should be reduced by 30­50% to prevent toxic accumulation of the drug. If safe and feasible, exchange transfusion may be considered for patients with severe malaria, although the precise indications for this procedure have not been agreed upon and there is no clear evidence that this measure is beneficial, particularly with artesunate treatment. If respiratory support is not available, a full loading dose of phenobarbital (20 mg/kg) to prevent convulsions should not be given as it may cause respiratory arrest. When the patient is unconscious, the blood glucose level should be measured every 4­6 h. All patients should receive a continuous infusion of dextrose, and blood concentrations ideally should be maintained above 4 mmol/L. Anemia develops rapidly; if the hematocrit falls to <20%, whole blood (preferably fresh) or packed cells should be transfused slowly, with careful attention to circulatory status. In areas with higher malaria transmission, where blood for transfusion is in short supply, a threshold of 15% is widely used. Children presenting with severe anemia and acidotic breathing require immediate blood transfusion. Rare: hypotension, blindness, deafness, cardiac arrhythmias, thrombocytopenia, hemolysis, hemolytic-uremic syndrome, vasculitis, cholestatic hepatitis, neuromuscular paralysis. Note: quinidine more cardiotoxic Acute: hypotensive shock (parenteral), cardiac arrhythmias, neuropsychiatric reactions. This and proguanil alone should not be given if the estimated glomerular filtration rate is <30 mL/min. Management of fluid balance is difficult in severe malaria, particularly in adults, because of the thin dividing line between overhydration (leading to pulmonary edema) and underhydration (contributing to renal impairment). Fluid balance management is different from that in sepsis: fluid boluses are potentially dangerous in severe malaria. Nasogastric feeding should be delayed in nonintubated patients (for 60 h in adults and 36 h in children) to reduce the risk of aspiration pneumonia. Mefloquine should be avoided as follow-on treatment for severe malaria because of the increased risk of post-malaria neurologic syndrome. Acute kidney injury, respiratory distress, and shock have all been described, but cerebral malaria does not occur. Treatment for severe vivax and knowlesi malaria should follow the recommendations given for falciparum malaria. The rapidly eliminated artemisinin component is usually an artemisinin derivative (artesunate, artemether, or dihydroartemisinin) given for 3 days, and the partner drug is usually a more slowly eliminated antimalarial to which P. There is increasing evidence for both the efficacy and the safety of artesunate-pyronaridine. Atovaquone-proguanil is highly effective everywhere, although it is seldom used in endemic areas because of its high cost and the propensity for rapid emergence of resistance. Extended treatment courses and triple antimalarial combinations are under evaluation. Tetracycline and doxycycline cannot be given to pregnant women after 15 weeks of gestation or to children <8 years of age. Oral quinine is extremely bitter and regularly produces cinchonism comprising tinnitus, high-tone deafness, nausea, vomiting, and dysphoria. Patients should be monitored for vomiting for 1 h after the administration of any oral antimalarial drug. Minor central nervous system reactions (nausea, dizziness, sleep disturbances) are common. The incidence of serious adverse neuropsychiatric reactions to mefloquine treatment is ~1 in 1000 in Asia but may be as high as 1 in 200 among Africans and Caucasians. All the antimalarial quinolines (chloroquine, mefloquine, and quinine) exacerbate the orthostatic hypotension associated with malaria, and all are tolerated better by children than by adults.

Buy myambutol 800 mg lowest price. Norsk Flooring - Raised Coin Pattern PVC Flooring.

References

• Feuers RJ, Delongchamp RR, Kramer S, Scheving LE, Casciano DA. The effect of age on the circadian rhythms of 23 liver or brain enzymes from C57BL/6J mice. Gerontology 1985;31:46-53.
• Gatzoulis MA, Freeman MA, Siu SC, et al: Atrial arrhythmia after surgical closure of atrial septal defects in adults, N Engl J Med 340:839-846, 1999.
• McMillan DE: Development of vascular complications in diabetes, Vasc Med 2(2):132-142, 1997.
• Adams JE 3rd, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: Is MB creatine kinase the choice for the 1990s? Circulation. 1993;88:750-763.
• Ringel SP, Forstot JZ, Tan EM, Wehling C, Griggs RC, Butcher D. Sjogren's syndrome and polymyositis or dermatomyositis. Arch Neurol. 1982;39(3):157-163.
• Yoshimura S, Toyoda K, Ohara T, et al. Takotsubo cardiomyopathy in acute ischemic stroke. Ann Neurol 2008;64:547-54.
• Gajewski JB, Schurch B, Hamid R, et al: An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD), Neurourol Urodyn 59:1438, 2017.
• Tespili M, Banfi C, Valsecchi O, et al. Endovascular treatment of thoracic aortic disease: mid-term follow-up. Catheter Cardiovasc Interv. 2007;70:595.